Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 11;22(1):60.
doi: 10.1186/s12876-022-02140-0.

Safety and efficacy of non-fluoroscopic endoscopic dilatation of gastrointestinal tuberculosis related strictures

Pankaj Kumar  1 , Anuraag Jena  1 , Chhagan Lal Birda  1 , Harjeet Singh  1 , Pankaj Gupta  1 , Kaushal Kishor Prasad  1 , Usha Dutta  1 , Vishal Sharma  2
Affiliations

Safety and efficacy of non-fluoroscopic endoscopic dilatation of gastrointestinal tuberculosis related strictures

Pankaj Kumar et al. BMC Gastroenterol. .

Abstract

Introduction: Stricturing gastrointestinal tuberculosis (GITB) may result in persistent symptoms even after antitubercular therapy (ATT) and may require surgical intervention. Data on efficacy and safety of endoscopic dilatation for management GITB related strictures is scarce.

Methods: A retrospective analysis of database of patients who underwent endoscopic balloon dilatation for suspected or proven gastrointestinal tuberculosis was performed. The analysis included the site of involvement, technical success, clinical success (response), relapse and requirement of surgery in these patients.

Results: Out of 34 patients (47.1% males, mean age 31.9 ± 12.9 years), eventually four patients were diagnosed to have Crohn's disease while the rest had GITB. Initial technical success was achieved in 30 (88.2%) patients. Initial clinical success was achieved in 28 (82.3%) patients. Median number of dilatation sessions required to obtain symptomatic relief were 2.5 (1-5) per patient. Two patients with initial clinical success had recurrence of symptoms over follow up of 1 year, out of which one patient was managed with repeat endoscopic balloon dilatation successfully. Of 30 patients with technical success, 16 (53.4%) were on ATT when they underwent dilatation while two were in intestinal obstruction. Eventually 7 patients required surgical intervention for various reasons.

Conclusion: Non-fluoroscopic endoscopic balloon dilatation is an acceptable and fairly safe modality for symptomatic tuberculous strictures of gastrointestinal tract.

Keywords: Abdominal tuberculosis; Colonoscopy; Crohn’s disease; Gastrointestinal tuberculosis; Intestinal tuberculosis; Surgery.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
A Terminal ileal stricture. B Endoscopic through the scope balloon negotiated across the stricture. C Stricture dilatation. D Post dilatation
Fig. 2
Fig. 2
Ileocecal stricture which could not be negotiated with a balloon
Fig. 3
Fig. 3
Flow chart showing the flow of the patients with clinical success and need for surgery
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Sharma V, Uma Debi U, Mandavdhare HS, Prasad KK, Tuberculosis and other mycobacterial infections of the abdomen. In: Kuipers EJ, editor. Encyclopedia of gastroenterology, 3rd ed. Academic Press: New York; p. 646–659. 10.1016/B978-0-12-801238-3.65963-9.
    1. Udgirkar S, Jain S, Pawar S, Chandnani S, Contractor Q, Rathi P. Clinical profile, drug resistance pattern and treatment outcomes of abdominal tuberculosis patients in western india. Arq Gastroenterol. 2019;56(2):178–183. doi: 10.1590/s0004-2803.201900000-35. - DOI - PubMed
    1. Shah J, Maity P, Kumar-M P, Jena A, Gupta P, Sharma V. Gastroduodenal tuberculosis: a case series and a management focused systematic review. Expert Rev Gastroenterol Hepatol. 2021;15(1):81–90. doi: 10.1080/17474124.2020.1816823. - DOI - PubMed
    1. Sharma V. Differentiating intestinal tuberculosis and Crohn disease: Quo Vadis. Expert Rev Gastroenterol Hepatol. 2020;14(8):647–650. doi: 10.1080/17474124.2020.1785870. - DOI - PubMed
    1. Anand BS, Nanda R, Sachdev GK. Response of tuberculous stricture to antituberculous treatment. Gut. 1988;29(1):62–69. doi: 10.1136/gut.29.1.62. - DOI - PMC - PubMed